The BE SURE study, comparing bimekizumab to Humira® (adalimumab) for the treatment of adults with moderate-to-severe plaque psoriasis, met all co-primary and ranked secondary endpoints BE SURE is the ...
Chronic plaque psoriasis is a condition in which epithelial cells are over produced and form a well-defined site. The redness is often covered with silvery scales of skin. The cause of this type of ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The investigational IL-17A and IL-17F inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback